Cleared Traditional

K895520 - PAGEWRITER XLI M1700A & PAGEWRITER XL M1701A (FDA 510(k) Clearance)

K895520 · Hewlett-Packard Co. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1990
Decision
308d
Days
-
Risk

K895520 is an FDA 510(k) clearance for the PAGEWRITER XLI M1700A & PAGEWRITER XL M1701A.

Submitted by Hewlett-Packard Co. (Mcminnville, US). The FDA issued a Cleared decision on July 17, 1990 after a review of 308 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Hewlett-Packard Co. devices

Submission Details

510(k) Number K895520 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 12, 1989
Decision Date July 17, 1990
Days to Decision 308 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
183d slower than avg
Panel avg: 125d · This submission: 308d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code LOS
Device Class -